期刊文献+

艰难梭菌毒素致病基因调控机制和抗毒素治疗 被引量:4

Regulatory Mechanism of Clostridium difficile Toxin-associated Pathogenic Gene and Anti-toxin Treatment
下载PDF
导出
摘要 艰难梭菌(C.difficile)是一种重要的院内感染病原体,是抗菌药物相关性腹泻的主要致病菌。C.difficile产毒菌株主要通过释放肠毒素A(Tcd A)和细胞毒素B(Tcd B)引起结肠损伤和炎症发生。研究发现C.difficile相关性疾病(CDAD)的严重程度与宿主体内细菌毒素水平相关。然而,不同菌株产毒能力差异较大,与毒素产生过程中涉及的基因调控密切相关。本文就C.difficile毒素致病基因调控机制和抗毒素治疗作一综述。 Abstract Clostridium diffwile (C. difficile) is a major nosocomial infection pathogen and the principal causative agent of antibiotic-associated diarrhea. The toxigenic C. difficile strains cause colonic injury and inflammation mainly by secreting enterotoxin A (TcdA) and cytotoxin B (TcdB). The severity of C. difficile associated disease (CDAD) is correlated to the toxin level during host infection. However, the toxigenic capacity of C. difficile varies widely among strains, which correlates with the gene regulation involved during toxin production. This article reviewed the regulatory mechanism of C. difficile toxin-associated pathogenic gene and anti-toxin treatment.
作者 林倩云 费稼希 陈烨 LIN Qianyun FEI Jiaxi CHEN Ye(Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangdong Provincial Key Laboratory of Gastroenterology, Guangzhou (510515)
出处 《胃肠病学》 2017年第1期47-50,共4页 Chinese Journal of Gastroenterology
关键词 难辨梭菌 细菌毒素类 基因调控 治疗 Clostridium difficile Bacterial Toxins Gene Regulation Therapy
  • 相关文献

参考文献2

二级参考文献68

  • 1Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe [J]. Lancet, 2005,366(9491):1079-1084. 被引量:1
  • 2McDonald L C, Killgore G E, Thompson A, et al. An epidemic, toxin genevariant strain of Clostridium difficile [J]. N Engl J Med, 2005, 353(23):2433-2441. 被引量:1
  • 3Drudy D, Harnedy N, Fanning S,et al. Isolation and characterization of toxin Anegative, toxin Bpositive Clostridium difficile in Dublin, Ireland [J]. Clin Microbiol Infect, 2007,13(3): 298 -304. 被引量:1
  • 4Shin B M, Kuak E Y, Yoo S J, et al. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea [J]. Diagn Microbiol Infect Dis, 2008,60(4):333-337. 被引量:1
  • 5Gerber M, Walch C, Lffler B, et al. Effect of subMIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile[J]. J Med Microbiol, 2008(Pt 6),57:776-783. 被引量:1
  • 6Govind R, Dupuy B. Secretion of Clostridium difficile toxins A and B requires the holinlike protein TcdE[J]. PLoS Pathog, 2012,8(6):e1002727. 被引量:1
  • 7Hawkey P M, Marriott C, Liu W E, et al. Molecular epidemiology of Clostridium difficile infection in a major Chinese hospital: an underrecognized problem in Asia ? [J]. J Clin Microbiol, 2013,51(10):3308-3313. 被引量:1
  • 8Huang H, Wu S, Wang M, et al. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes [J]. Int J Antimicrob Agents, 2009, 33(4): 339-342. 被引量:1
  • 9Martin H, Willey B, Low D E, et al, Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006 [J]. J Clin Microbiol, 2008, 46(9): 2999-3004. 被引量:1
  • 10Lyerly D M, Saum K E, MacDonald D K, et al. Effects of Clostridium difficile toxins given intragastrically to animals [J]. Infect Immun, 1985,47(2):349-352. 被引量:1

共引文献9

同被引文献26

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部